Rapid developments across disciplines are fueling momentum in advances in respiratory medicine, which spans imaging, therapeutics, precision diagnostics, and systems-based care. High-resolution modalities, digital stethoscopes, and handheld spirometry are transforming how respiratory symptoms are evaluated at the point of care. Biologics, antifibrotics, and novel anti-infectives have created new frontiers for managing chronic and acute lung diseases. Advances in Respiratory Medicine also integrates health informatics, remote monitoring, and personalized medicine to offer proactive and predictive care. Multi-omics research is uncovering disease mechanisms that were previously inaccessible, enabling earlier intervention and targeted therapy. The convergence of innovation and clinical application is shaping a new standard—where prevention, intervention, and rehabilitation are guided by real-time data and patient-specific insights.
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Non-canonical IRF3 functions in limiting pulmonary inflammation
Saurabh Chattopadhyay, University of Kentucky, United States
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : The representational challenge for designing and managing intelligent and ethical 5P medicine pulmonary, respiratory and lung health care systems
Habil Bernd Blobel, University of Regensburg, Germany
Title : From Chronic Obstructive Pulmonary Disease (COPD) to Non-Small Cell Lung Cancer (NSCLC): T helper cell epigenetic modifications and cancer risk
Koustav Sarkar, SRM Institute of Science and Technology, India
Title : Bacterial profile of community acquired pneumonia in a public health institute
Sayan Bhattacharyya, AIIH&PH, India